Schizophrenia.
D000359:Aftercare; D000978:Antiparkinson Agents / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005476:Fluphenazine / Q000009:adverse effects / Q000627:therapeutic use; D006782:Hospitals, Special; D006801:Humans; D009732:Nursing Care; D010640:Phenothiazines / Q000627:therapeutic use; D012050:Rehabilitation, Vocational; D012559:Schizophrenia / Q000188:drug therapy* / Q000534:rehabilitation; D013892:Thioxanthenes / Q000627:therapeutic use
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D010640:Phenothiazines; D013892:Thioxanthenes; D005476:Fluphenazine